Evidence map›Paper›PMID 27826818›Full record

ArticleJournal of racial and ethnic health disparities2016

A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers.

Zachary R Simoni, Michelle Martin, Jennifer A Wenzel, Elise D Cook, Badrinath Konety, Selwyn M Vickers, Moon S Chen, Mona N Foaud, Raegan W Durant

Erratum issuedAbstract read
In one paragraph

Article in Journal of racial and ethnic health disparities, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Zachary R SimoniUniversity of Texas at Dallas, Dallas, TX, USA. zackrsimoni@gmail.com.
Michelle MartinUniversity of Texas at Dallas, Dallas, TX, USA.
Jennifer A WenzelUniversity of Texas at Dallas, Dallas, TX, USA.
Elise D CookUniversity of Texas at Dallas, Dallas, TX, USA.
Badrinath KonetyUniversity of Texas at Dallas, Dallas, TX, USA.
Selwyn M VickersUniversity of Texas at Dallas, Dallas, TX, USA.
Moon S ChenUniversity of Texas at Dallas, Dallas, TX, USA.
Mona N FoaudUniversity of Texas at Dallas, Dallas, TX, USA.
Raegan W DurantUniversity of Texas at Dallas, Dallas, TX, USA.

Funding

UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
Research ProjectU54CA153499 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, MOON SHAO-CHUANG, CHOW, EDWARD A. · 2010 to 2015
$6.7M
Enhancing Minority Participation in Clinical Trials (EMPaCT):Phase IIU24MD006970 · NIMHD · UNIVERSITY OF MINNESOTA · PI DURANT, RAEGAN WINSTON, FOUAD, MONA N. · 2011 to 2015
$4.9M
Enhancing Minority Participation in Clinical Trials (EMPaCT)RC2MD004797 · NIMHD · UNIVERSITY OF MINNESOTA · PI FOUAD, MONA N., VICKERS, SELWYN M · 2009 to 2010
$4.2M
NCATS NIH HHS UL1 TR001417NCI NIH HHS U54 CA153499NIMHD NIH HHS L60 MD000497NIMHD NIH HHS RC2 MD004797NIMHD NIH HHS U24 MD006970
6 · The paper itself

Abstract

backgroundMinority enrollment in cancer clinical trials is traditionally low. In light of this fact, numerous studies have investigated barriers to recruitment and retention within minority populations. However, very little research has investigated the importance of clinicians' and researchers' motivations for minority recruitment in cancer clinical trials. Therefore, we sought to examine motivations for minority recruitment across four professional stakeholder groups (principal investigators, clinicians, research staff, and Cancer Center leaders) at five National Cancer Institute (NCI)-designated Comprehensive Cancer Centers.

methodsThis study is based on the data from 91 qualitative interviews conducted across the five NCI-designated Comprehensive Cancer Centers to investigate stakeholders' motivations for minority recruitment in cancer clinical trials.

resultsEmergent themes include (a) minority recruitment increases generalizability of cancer clinical trials, (b) minority recruitment is motivated by social justice, (c) some institutions promote minority recruitment through the use of supplemental financial support, (d) federal funding requirements for minority inclusion in clinical research motivate investigators to focus on minority recruitment, and (e) some stakeholders favor a more race-neutral approach to participant recruitment rather than an emphasis on targeted minority recruitment.

conclusionThe perspectives of clinical and research stakeholders potentially inform the assessment of existing strategies and the development of new strategies to increase motivation for minority recruitment in cancer clinical trials.

Indexed as

Cancer clinical trialsMinority recruitmentMotivations for minority recruitmentStakeholders

Identifiers

PMID27826818
PMCPMC6110968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.